PRECLINICAL DEVELOPMENT OF NOVEL PARATHYROID HORMONE-RELATED PEPTIDE ANTAGONIST FOR BREAST CANCER

$388,936FY2016Department of the ArmyDOD

Tufts Medical Center Parent, Inc.

Investigators